A CTLA-4 Antagonizing DNA Aptamer with Antitumor Effect

The successful translation of cytotoxic T lymphocyte antigen-4 (CTLA-4) blockade has revolutionized the concept of cancer immunotherapy. Although monoclonal antibody therapeutics remain the mainstream in clinical practice, aptamers are synthetic oligonucleotides that encompass antibody-mimicking fun...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Bo-Tsang, Lai, Wei-Yun, Chang, Yi-Chung, Wang, Jen-Wei, Yeh, Shauh-Der, Lin, Emily Pei-Ying, Yang, Pan-Chyr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573796/
https://www.ncbi.nlm.nih.gov/pubmed/28918052
http://dx.doi.org/10.1016/j.omtn.2017.08.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5573796/
https://www.ncbi.nlm.nih.gov/pubmed/28918052
http://dx.doi.org/10.1016/j.omtn.2017.08.006

Ejemplares similares